Effects of digital meditation on cognition and wellbeing in older adults
A Pilot Study of the Impact of Personalized Digital Meditation on Improving Sleep and Reducing Stress in MCI
NA · University of California, San Francisco · NCT06633978
This study is testing if a new digital meditation program can help improve thinking skills and sleep quality in older adults, especially those with mild cognitive impairment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 60 Years to 85 Years |
| Sex | All |
| Sponsor | University of California, San Francisco (other) |
| Drugs / interventions | Radiation |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT06633978 on ClinicalTrials.gov |
What this trial studies
This research aims to evaluate the impact of a novel closed-loop digital meditation program called MediTrain on cognitive abilities and sleep quality in older adults, particularly those with mild cognitive impairment (MCI). Participants will wear multi-sensor watches and sleep monitors to gather data on their cognitive performance, stress levels, and sleep patterns. The study will compare the outcomes of those with MCI to cognitively healthy older adults, providing insights into the effectiveness of digital interventions in enhancing cognitive health and overall wellbeing.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 60-85 who are ambulatory and have no significant neurological or psychiatric disorders.
Not a fit: Patients with severe cognitive impairment or those taking medications that affect mood or cognition may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved cognitive function and sleep quality in older adults, particularly those experiencing mild cognitive impairment.
How similar studies have performed: Other studies have shown promising results with digital interventions for cognitive enhancement, suggesting potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
* comfortably ambulatory healthy physical condition * normal or corrected to normal visual * auditory acuity * fluency in spoken English * Between 60-85 years old * No neurological or psychiatric disorders * No substance abuse * Not taking anti-depressants * Not taking anti-anxiety medication * No history of seizures * No color blindness * No glaucoma * No macular degeneration * No amblyopia (lazy eye) * No strabismus (cross eyed) * Aneurysm clip(s) * No Cardiac pacemaker * No Implanted cardioverter defibrillator (ICD) * No Electronic implant or device * No Magnetically-activated implant or device * No Neurostimulation system * No Spinal cord stimulator * No Internal electrodes or wires * No Bone growth/bone fusion stimulator * No Cochlear, otologic, or other ear implant * No Insulin or other infusion pump * No Implanted drug infusion device * No type of prosthesis (eye, penile, etc.) * No Heart valve prosthesis * No Eyelid spring or wire * No Artificial or prosthetic limb * No Metallic stent, filter, or coil * No Shunt (spinal or intraventricular) * No Vascular access port and/or catheter * No Radiation seeds or implants * No Swan-Ganz or thermodilution catheter * No Medication patch (Nicotine, Nitroglycerine) * No metallic fragment or metallic foreign body in/on the body that can not be removed * No Wire mesh implant * No Tissue expander (e.g., breast) * No Surgical staples, clips, or metallic sutures * No Joint replacement (hip, knee, etc.) * No Bone/joint pin, screw, nail, wire, plate, etc. * No IUD, diaphragm, or pessary * No Dentures or partial plates that can not be removed * No Tattoo or permanent makeup * No Body piercing jewelry * No Claustrophobia
Where this trial is running
San Francisco, California
- University of California, San Francisco — San Francisco, California, United States (RECRUITING)
Study contacts
- Principal investigator: David A Ziegler, PhD — University of California, San Francisco
- Study coordinator: Joseph Chen, PhD
- Email: medidream@ucsf.edu
- Phone: 415-476-2164
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: MCI, Aging, meditation, sleep, stress, attention, cognition, memory